OGI Bio
PrivateLast Round
VC Round
Jul 22, 2025
Total Funding Raised
$3.02M
Company Overview
OGI Bio operates in Healthcare & Life Sciences and is based in Edinburgh. Its latest recorded funding round was a VC Round in July 2025.
OGI Bio is a biotechnology company that develops and provides automated, modular bioreactor systems to streamline and enhance microbial research and culturing processes.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OGI Bio Comparables
Compare OGI Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellexus | 84% | |
| LAMBDA Laboratory Instruments | 81% | |
| Belach Bioteknik AB | 78% |
For institutional investors. Book with your work email.
OGI Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 22, 2025 | ||||
| Seed | Jun 4, 2024 | ||||
| Seed | May 30, 2023 | ||||
| Seed | Apr 29, 2022 | ||||
| Pre Seed | Mar 1, 2022 | ||||
Grant | Nov 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OGI Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QUBIS | Seed |
| Sapphire Capital Partners | Seed |
| Apollo Informal Investment | Seed, VC Round, Pre Seed, Grant |
| Innovate UK | Grant |
| Old College Capital | Seed |
| Merleview Capital | Seed, VC Round |
| The TRICAPITAL Syndicate | VC Round, Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2025
Led by Merleview Capital with participation from Apollo Informal Investment.
- Jun 4, 2024
$826K round with Apollo Informal Investment and Old College Capital.
For institutional investors. Book with your work email.
OGI Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OGI Bio's valuation, stock price, and market status.
Is OGI Bio a public or private company?
OGI Bio is a private company.
What is the current stock price of OGI Bio?
OGI Bio is a private company, so its shares have no public market price. Caplight tracks OGI Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OGI Bio worth (valuation)?
Valuation information for OGI Bio is not publicly available.
Can I buy OGI Bio stock?
OGI Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OGI Bio's last funding round?
OGI Bio's most recent funding round was VC Round on July 22, 2025.
Who are the main investors in OGI Bio?
Key investors in OGI Bio include Apollo Informal Investment, Merleview Capital, The TRICAPITAL Syndicate.
Will OGI Bio IPO soon?
No public IPO plans have been announced for OGI Bio.
How can I track OGI Bio secondary market activity?
Caplight tracks bids, offers, and trades in OGI Bio's shares on secondary markets.